Clinical Trial

ML-016 in Advanced Cancer With Lung and/or Liver Involvement

Name: ML-016 in Advanced Cancer With Lung and/or Liver Involvement — clinical trial record (NCT07723482)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is an open-label, multi-center, phase 1/2 dose-escalation and dose expansion study evaluating the safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of ML-016 in participants with advanced solid tumors with lung and/or liver involvement (primary or metastatic disease).

Trial Details

NCT Number	NCT07723482
Lead Sponsor	BrYet US, Inc. Collaborators: Southern Star Research
Conditions	Advanced Solid Tumor With Lung and/or Liver Involvement
Enrollment	108 participants
Start Date	2026-08
Primary Completion	2027-08 (estimated)
Study Completion	2030-08 (estimated)
Updated on ClinicalTrials.gov	2026-07-23